ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

ACS Survey Finds Need for Cancer Education Among Hispanic Americans

August 2, 1985

NCI Funds New Centers At Stanford, Baylor.

June 15, 2007

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30

September 20, 1974